Global Over the Counter Analgesics Market Size study, by Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory, Salicylates, Other Analgesics), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels) and Regional Forecasts 2021-2027
Global Over the Counter Analgesics Market is valued at approximately USD 25.1 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.5 % over the forecast period 2021-2027. Over The Counter Analgesics are over-the-counter pain medications that can be bought without a prescription. They are primarily used for the treatment of menstrual cramps, musculoskeletal injuries, arthritis, toothaches, flu, colds, fever and headaches. Increasing demand of topical analgesics is expected to fuel the Over-the-Counter Analgesics market, Topical analgesics is a medication applied to the body surfaces such as skin or mucus membranes to treat painful ailments. Growth in the geriatric population and rising prevalence of various diseases is propelling the market growth. For instance, the European Medicine agency has recommended using non-steroidal anti-inflammatories, such as ibuprofen and paracetamol, to treat mild symptoms of COVID-19 in lowest dose form. Moreover, New product launches by several key players are expected to influence the market positively. For instance,
• In March, 2021, Hisamitsu Pharmaceuticals Co, Inc launched Salonpas Arthritis Pain Relief Gel. The medicine is prescription strength diclofenac, which was approved by the FDA for over-the-counter use in 2020.
• In September 2020, Dr. Reddy’s Laboratories launched over-the-counter Diclofenac Sodium topic gel, used for arthritis pain, in United States.
However, threat of drug tolerance, dependence, addiction and abuse may impede market growth over the forecast period of 2021-2027.
The regional analysis of the global Over the Counter Analgesics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to high preference of patients in the region, to treat minor ailments with OTC medications before seeking professional help.
Major market player included in this report are:
Bayer AG
Boehringer Ingelheim International GmbH
Johnson & Johnson
GlaxoSmithKline PLC
Pfizer Inc.
Reckitt Benckiser Group PLC
Sanofi SA
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company Limited
AstraZeneca PLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Acetaminophen
Nonsteroidal Anti-inflammatory
Salicylates
Other Analgesics
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018-19
Base year – 2019-2020
Forecast period – 2021 to 2027.
Target Audience of the Global Over the Counter Analgesics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
• In March, 2021, Hisamitsu Pharmaceuticals Co, Inc launched Salonpas Arthritis Pain Relief Gel. The medicine is prescription strength diclofenac, which was approved by the FDA for over-the-counter use in 2020.
• In September 2020, Dr. Reddy’s Laboratories launched over-the-counter Diclofenac Sodium topic gel, used for arthritis pain, in United States.
However, threat of drug tolerance, dependence, addiction and abuse may impede market growth over the forecast period of 2021-2027.
The regional analysis of the global Over the Counter Analgesics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to high preference of patients in the region, to treat minor ailments with OTC medications before seeking professional help.
Major market player included in this report are:
Bayer AG
Boehringer Ingelheim International GmbH
Johnson & Johnson
GlaxoSmithKline PLC
Pfizer Inc.
Reckitt Benckiser Group PLC
Sanofi SA
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company Limited
AstraZeneca PLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Acetaminophen
Nonsteroidal Anti-inflammatory
Salicylates
Other Analgesics
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018-19
Base year – 2019-2020
Forecast period – 2021 to 2027.
Target Audience of the Global Over the Counter Analgesics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Over the Counter Analgesics market, by Type of Drug, 2019-2027 (USD Billion)
1.2.2. Over the Counter Analgesics, by Distribution Channel, 2019-2027 (USD Billion)
1.2.3. Over the Counter Analgesics, by Region, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OVER THE COUNTER ANALGESICS DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OVER THE COUNTER ANALGESICS DYNAMICS
3.1. Over the Counter Analgesics Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing demand in tropical analgesics
3.1.1.2. Growth in the geriatric population
3.1.2. Market Restraint
3.1.2.1. Drug abuse and possibility of drug addiction
3.1.3. Market Opportunities
3.1.3.1. Growing aging population
CHAPTER 4. GLOBAL OVER THE COUNTER ANALGESICS INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL OVER THE COUNTER ANALGESICS, BY TYPE OF DRUGS
5.1. Market Snapshot
5.2. Global Over the Counter Analgesics by Type , Performance - Potential Analysis
5.3. Global Over the Counter Analgesics Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Over the Counter Analgesics, Sub Segment Analysis
5.4.1. Acetaminophen
5.4.2. Nonsteroidal Anti-inflammatory drug
5.4.3. Salicylates
5.4.4. Other Analgesics
CHAPTER 6. GLOBAL OVER THE COUNTER ANALGESICS, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Over the Counter Analgesics by Application, Performance - Potential Analysis
6.3. Global Over the Counter Analgesics Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Over the Counter Analgesics, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
6.4.4. Other Distribution Channels
CHAPTER 7. GLOBAL OVER THE COUNTER ANALGESICS, REGIONAL ANALYSIS
7.1. Over the Counter Analgesics, Regional Market Snapshot
7.2. North America Over the Counter Analgesics
7.2.1. U.S. Over the Counter Analgesics
7.2.1.1. Type breakdown estimates & forecasts, 2018-2027
7.2.1.2. Application breakdown estimates & forecasts, 2018-2027
7.2.1.3. End use breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Over the Counter Analgesics
7.3. Europe Over the Counter Analgesics Snapshot
7.3.1. U.K. Over the Counter Analgesics
7.3.2. Germany Over the Counter Analgesics
7.3.3. France Over the Counter Analgesics
7.3.4. Spain Over the Counter Analgesics
7.3.5. Italy Over the Counter Analgesics
7.3.6. Rest of Europe Over the Counter Analgesics
7.4. Asia-Pacific Over the Counter Analgesics Snapshot
7.4.1. China Over the Counter Analgesics
7.4.2. India Over the Counter Analgesics
7.4.3. Japan Over the Counter Analgesics
7.4.4. Australia Over the Counter Analgesics
7.4.5. South Korea Over the Counter Analgesics
7.4.6. Rest of Asia Pacific Over the Counter Analgesics
7.5. Latin America Over the Counter Analgesics Snapshot
7.5.1. Brazil Over the Counter Analgesics
7.5.2. Mexico Over the Counter Analgesics
7.6. Rest of The World Over the Counter Analgesics
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Bayer AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
9.2.2 Boehringer Ingelheim International GmbH
9.2.3 Johnson & Johnson
9.2.4 GlaxoSmithKline PLC
9.2.5 Pfizer Inc.
9.2.6 Reckitt Benckiser Group PLC
9.2.7 Sanofi SA
9.2.8 Sun Pharmaceutical Industries Ltd
9.2.9 Takeda Pharmaceutical Company Limited
9.2.10 AstraZeneca PLC
CHAPTER 9. RESEARCH APPLICATION
9.1. Research Application
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Over the Counter Analgesics market, by Type of Drug, 2019-2027 (USD Billion)
1.2.2. Over the Counter Analgesics, by Distribution Channel, 2019-2027 (USD Billion)
1.2.3. Over the Counter Analgesics, by Region, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OVER THE COUNTER ANALGESICS DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OVER THE COUNTER ANALGESICS DYNAMICS
3.1. Over the Counter Analgesics Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing demand in tropical analgesics
3.1.1.2. Growth in the geriatric population
3.1.2. Market Restraint
3.1.2.1. Drug abuse and possibility of drug addiction
3.1.3. Market Opportunities
3.1.3.1. Growing aging population
CHAPTER 4. GLOBAL OVER THE COUNTER ANALGESICS INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL OVER THE COUNTER ANALGESICS, BY TYPE OF DRUGS
5.1. Market Snapshot
5.2. Global Over the Counter Analgesics by Type , Performance - Potential Analysis
5.3. Global Over the Counter Analgesics Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Over the Counter Analgesics, Sub Segment Analysis
5.4.1. Acetaminophen
5.4.2. Nonsteroidal Anti-inflammatory drug
5.4.3. Salicylates
5.4.4. Other Analgesics
CHAPTER 6. GLOBAL OVER THE COUNTER ANALGESICS, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Over the Counter Analgesics by Application, Performance - Potential Analysis
6.3. Global Over the Counter Analgesics Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Over the Counter Analgesics, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
6.4.4. Other Distribution Channels
CHAPTER 7. GLOBAL OVER THE COUNTER ANALGESICS, REGIONAL ANALYSIS
7.1. Over the Counter Analgesics, Regional Market Snapshot
7.2. North America Over the Counter Analgesics
7.2.1. U.S. Over the Counter Analgesics
7.2.1.1. Type breakdown estimates & forecasts, 2018-2027
7.2.1.2. Application breakdown estimates & forecasts, 2018-2027
7.2.1.3. End use breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Over the Counter Analgesics
7.3. Europe Over the Counter Analgesics Snapshot
7.3.1. U.K. Over the Counter Analgesics
7.3.2. Germany Over the Counter Analgesics
7.3.3. France Over the Counter Analgesics
7.3.4. Spain Over the Counter Analgesics
7.3.5. Italy Over the Counter Analgesics
7.3.6. Rest of Europe Over the Counter Analgesics
7.4. Asia-Pacific Over the Counter Analgesics Snapshot
7.4.1. China Over the Counter Analgesics
7.4.2. India Over the Counter Analgesics
7.4.3. Japan Over the Counter Analgesics
7.4.4. Australia Over the Counter Analgesics
7.4.5. South Korea Over the Counter Analgesics
7.4.6. Rest of Asia Pacific Over the Counter Analgesics
7.5. Latin America Over the Counter Analgesics Snapshot
7.5.1. Brazil Over the Counter Analgesics
7.5.2. Mexico Over the Counter Analgesics
7.6. Rest of The World Over the Counter Analgesics
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Bayer AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
9.2.2 Boehringer Ingelheim International GmbH
9.2.3 Johnson & Johnson
9.2.4 GlaxoSmithKline PLC
9.2.5 Pfizer Inc.
9.2.6 Reckitt Benckiser Group PLC
9.2.7 Sanofi SA
9.2.8 Sun Pharmaceutical Industries Ltd
9.2.9 Takeda Pharmaceutical Company Limited
9.2.10 AstraZeneca PLC
CHAPTER 9. RESEARCH APPLICATION
9.1. Research Application
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Over the Counter Analgesics, report scope
TABLE 2. Global Over the Counter Analgesics estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Over the Counter Analgesics estimates & forecasts by Drug Type 2018-2027 (USD Billion)
TABLE 4. Global Over the Counter Analgesics estimate & forecasts by Distribution Channel 2018-2027 (USD Billion)
TABLE 5. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. U.S. Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Canada Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Canada Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. UK Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. UK Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. Germany Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. Germany Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. France Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. France Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Spain Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Spain Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Italy Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. Italy Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. ROE Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. ROE Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. China Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. China Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. India Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. India Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Japan Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Japan Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Australia Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 55. Australia Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. South Korea Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 58. South Korea Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. ROPAC Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 61. ROPAC Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. Brazil Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 64. Brazil Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Mexico Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 67. Mexico Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. ROLA Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 70. ROLA Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROW Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 73. ROW Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. List of secondary sources used in the study of global Over the Counter Analgesics.
TABLE 76. List of primary sources used in the study of global Over the Counter Analgesics.
TABLE 77. Years considered for the study.
TABLE 78. Exchange rates considered.
TABLE 1. Global Over the Counter Analgesics, report scope
TABLE 2. Global Over the Counter Analgesics estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Over the Counter Analgesics estimates & forecasts by Drug Type 2018-2027 (USD Billion)
TABLE 4. Global Over the Counter Analgesics estimate & forecasts by Distribution Channel 2018-2027 (USD Billion)
TABLE 5. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Over the Counter Analgesics by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Over the Counter Analgesics by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. U.S. Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Canada Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Canada Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. UK Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. UK Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. Germany Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. Germany Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. France Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. France Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Spain Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Spain Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Italy Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. Italy Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. ROE Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. ROE Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. China Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. China Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. India Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. India Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Japan Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Japan Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Australia Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 55. Australia Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. South Korea Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 58. South Korea Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. ROPAC Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 61. ROPAC Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. Brazil Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 64. Brazil Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Mexico Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 67. Mexico Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. ROLA Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 70. ROLA Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROW Over the Counter Analgesics estimates & forecasts, 2018-2027 (USD Billion)
TABLE 73. ROW Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Over the Counter Analgesics estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. List of secondary sources used in the study of global Over the Counter Analgesics.
TABLE 76. List of primary sources used in the study of global Over the Counter Analgesics.
TABLE 77. Years considered for the study.
TABLE 78. Exchange rates considered.
LIST OF FIGURES
FIG 1. Global Over the Counter Analgesics, research methodology
FIG 2. Global Over the Counter Analgesics, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Over the Counter Analgesics, key trends 2019
FIG 5. Global Over the Counter Analgesics, growth prospects 2020-2027
FIG 6. Global Over the Counter Analgesics, porters 5 force model
FIG 7. Global Over the Counter Analgesics, pest analysis
FIG 8. Global Over the Counter Analgesics, value chain analysis
FIG 9. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Over the Counter Analgesics, regional snapshot 2018 & 2027
FIG 18. North America Over the Counter Analgesics 2018 & 2027 (USD Billion)
FIG 19. Europe Over the Counter Analgesics 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Over the Counter Analgesics 2018 & 2027 (USD Billion)
FIG 21. Latin America Over the Counter Analgesics 2018 & 2027 (USD Billion)
FIG 22. Global Over the Counter Analgesics, company market share analysis (2019)
FIG 1. Global Over the Counter Analgesics, research methodology
FIG 2. Global Over the Counter Analgesics, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Over the Counter Analgesics, key trends 2019
FIG 5. Global Over the Counter Analgesics, growth prospects 2020-2027
FIG 6. Global Over the Counter Analgesics, porters 5 force model
FIG 7. Global Over the Counter Analgesics, pest analysis
FIG 8. Global Over the Counter Analgesics, value chain analysis
FIG 9. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Over the Counter Analgesics by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Over the Counter Analgesics, regional snapshot 2018 & 2027
FIG 18. North America Over the Counter Analgesics 2018 & 2027 (USD Billion)
FIG 19. Europe Over the Counter Analgesics 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Over the Counter Analgesics 2018 & 2027 (USD Billion)
FIG 21. Latin America Over the Counter Analgesics 2018 & 2027 (USD Billion)
FIG 22. Global Over the Counter Analgesics, company market share analysis (2019)
